Skip to main content
    D

    Definitive Healthcare Corp (DH)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $1.26
    -0.05 (-3.82%)

    Market Cap: $140.38M

    Last updated: Nov 17, 2026 at 11:02 AM ET

    Definitive Healthcare Corp (DH) Earnings: Report Dates and Results

    Updated Nov 5, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Definitive Healthcare (DH) is expected to report earnings on Feb 24, 2027. In the quarter ended Sep 30, 2026, Definitive Healthcare reported EPS of $0.01, in line with the $0.01 estimate. It beat the EPS estimate in 5 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    64%(14/22)
    Avg Surprise
    +38.13%

    Upcoming Estimates

    Reports Feb 24, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.04
    Range$0.03 - $0.06
    9 analysts
    Revenue Consensus
    $57.23M
    Range$54.21M - $58.70M
    7 analysts
    Reports May 5, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.05
    Range$0.04 - $0.05
    5 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$0.05+1.5%
    60d ago$0.05-1.1%
    30d ago$0.05-1.1%
    7d ago$0.05-1.1%
    Current$0.05
    Revenue Consensus
    $56.08M
    Range$53.74M - $58.17M
    4 analysts

    Next Report

    DH has an expected report date of Feb 24, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 33.3% below the $0.06 reported for the quarter ended Dec 31, 2025.

    DH Earnings Call

    The latest DH earnings call transcript on file is labeled 2026Q2.

    Read the 2026Q2 transcript

    Earnings History

    Of the 22 quarters below that had an estimate, DH beat 14, missed 3 and matched 5. Revenue for the quarter ended Sep 30, 2026 was $54.65M, down 9.0% from $60.05M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.01$0.01N/A0.00%In line-85.7%60 up, 2 downNov 5, 2026$54.65M
    Jun 30, 2026$0.01$0.04$0.04 - $0.05-75.00%Miss-50.0%71 up, 0 downAug 10, 2026$55.20M
    Mar 31, 2026$0.06$0.03$0.03 - $0.04+100.00%Beat+20.0%110 up, 7 downMay 7, 2026$55.93M
    Dec 31, 2025$0.06$0.03N/A+100.00%Beat-25.0%110 up, 3 downFeb 26, 2026$61.53M
    Sep 30, 2025$0.07$0.06$0.05 - $0.06+16.67%Beat-30.0%111 up, 4 downNov 6, 2025$60.05M
    Jun 30, 2025$0.02$0.02N/A0.00%In line-77.8%123 up, 2 downAug 7, 2025$60.75M
    Mar 31, 2025$0.05$0.02$0.02 - $0.04+150.00%Beat-37.5%120 up, 8 downMay 8, 2025$59.19M
    Dec 31, 2024$0.08$0.07$0.07 - $0.08+11.42%Beat+14.3%132 up, 3 downFeb 27, 2025$62.29M
    Sep 30, 2024$0.10$0.08$0.07 - $0.09+25.00%Beat+11.1%120 up, 0 downNov 7, 2024$62.70M
    Jun 30, 2024$0.09$0.09$0.08 - $0.090.00%In line+12.5%121 up, 1 downAug 5, 2024$63.74M
    Mar 31, 2024$0.08$0.08$0.08 - $0.090.00%In line+33.3%120 up, 0 downMay 7, 2024$63.48M
    Dec 31, 2023$0.07$0.08$0.06 - $0.09-12.50%Miss0.0%120 up, 0 downFeb 28, 2024$65.93M
    Sep 30, 2023$0.09$0.06$0.05 - $0.08+50.00%Beat+50.0%110 up, 0 downNov 2, 2023$65.33M
    Jun 30, 2023$0.08$0.06$0.04 - $0.08+33.33%Beat+33.3%133 up, 0 downAug 14, 2023$60.96M
    Mar 31, 2023$0.06$0.04$0.04 - $0.05+50.00%Beat+20.0%130 up, 0 downMay 4, 2023$59.20M
    Dec 31, 2022$0.07$0.04$0.04 - $0.05+75.00%Beat+75.0%121 up, 0 downFeb 23, 2023$60.60M
    Sep 30, 2022$0.06$0.05$0.04 - $0.05+20.00%Beat+500.0%100 up, 0 downNov 3, 2022$57.38M
    Jun 30, 2022$0.06$0.05$0.05 - $0.06+20.00%Beat+50.0%100 up, 0 downAug 4, 2022$54.55M
    Mar 31, 2022$0.05$0.04$0.03 - $0.04+25.00%BeatN/A100 up, 0 downMay 5, 2022$50.12M
    Dec 31, 2021$0.04$0.04$0.04 - $0.050.00%In lineN/A100 up, 0 downFeb 23, 2022$46.31M
    Sep 30, 2021$0.01$0.02$0.01 - $0.02-50.00%MissN/A8N/ANov 8, 2021$43.08M
    Jun 30, 2021$0.04$0.01N/A+300.00%BeatN/AN/AN/ASep 16, 2021$39.82M
    Mar 31, 2021-$0.10N/AN/AN/AN/AN/AN/AN/AJun 30, 2021$36.94M
    Dec 31, 2020-$0.10N/AN/AN/AN/AN/AN/AN/AMar 31, 2021$33.66M
    Last 24 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $0.20, down 42.9% from the year before. It was -$0.10 for the year ended Dec 31, 2020, the oldest of the 6 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$0.20-42.9%
    Dec 31, 2024$0.35+16.7%
    Dec 31, 2023$0.30+25.0%
    Dec 31, 2022$0.24N/A
    Dec 31, 2021-$0.01N/A
    Dec 31, 2020-$0.10N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q2 for the period ended Jun 30, 2026, runs about 4,300 words across 6 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q2Jun 30, 20264,2796
    2026Q1Mar 31, 20265,67010
    2025Q4Dec 31, 20256,9659
    2025Q3Sep 30, 20256,89910
    2025Q2Jun 30, 20256,52310
    2025Q1Mar 31, 20256,86810
    2024Q4Dec 31, 20246,64912
    2024Q3Sep 30, 20246,42610

    2026Q2 Earnings Call

    Opening remarks

    Jonathan Paris Investor Relations Good afternoon, and thank you for joining us to review Definitive Healthcare's financial results. Joining me on today's call are Kevin Coop, our Chief Executive Officer, and Casey Heller, our Chief Financial Officer. Before we begin, I'd like to remind you that today's discussion may include forward-looking statements within the meaning of the federal securities laws, including the Private Securities Litigation Reform Act of 1995. These statements include, among others, statements about our market opportunity, future performance, growth in financial guidance, the benefits of our data and health and commercial intelligence solutions, our competitive position, customer behavior, adoption, growth, renewals, and retention, planned investments and operating strategy, value creation for customers and shareholders, and the expected impact of macroeconomic conditions on our business, customers, and the healthcare industry. Forward-looking statements are based on our current expectations and assumptions as of today and are subject to risks and uncertainties that could cause actual results to differ materially. For more information, please refer to the cautionary statement in today's earnings release, as well as the risk factors and other information included in our filings with the SEC, including our most recent Form 10-K and Form 10-Q. You should not place undue reliance on forward-looking statements, and Definitive Healthcare undertakes no obligation to update them except as required by law. During the call, we may also discuss certain non-GAAP financial measures. Reconciliations to the most directly comparable GAAP measures, along with related definitions and limitations, are included in today's earnings release and investor presentation, each of which is available on the Investor Relations section of our website. For any forward-looking non-GAAP measures, the earnings release also explains why quantitative reconciliation is not available without unreasonable efforts and identifies the relevant unavailable items. With that, I'll turn the call over to Kevin.

    Kevin Coop Chief Executive Officer Thank you, Jonathan, and thanks to all of you for joining us this afternoon to review Definitive Healthcare's second quarter 2026 financial results. On today's call, I'll provide highlights from our second quarter performance and give an update on our progress against our key strategic priorities for this year. Let me begin by reviewing our financial results for the second quarter, which were in line or exceeded the guidance ranges on both the top and bottom line. Total revenue was $55.2 million, down 9% year-over-year. Adjusted EBITDA was $14.6 million, representing a margin of 26%, which was modestly above the high end of our guidance. We continue to do an effective job of managing expenses while investing in our core growth initiatives. We continue to generate solid cash flow, delivering approximately $50 million of unlevered free cash flow for the trailing 12 months.

    Frequently Asked Questions About DH

    When is Definitive Healthcare's next earnings date?

    Definitive Healthcare's next earnings report is expected for Feb 24, 2027.

    Did DH beat earnings estimates last quarter?

    Definitive Healthcare reported EPS of $0.01 for the quarter ended Sep 30, 2026, in line with the $0.01 estimate.

    What EPS do analysts expect from DH next quarter?

    The consensus EPS estimate for Definitive Healthcare for the quarter ending Dec 31, 2026 is $0.04 from 9 analysts, with estimates from $0.03 to $0.06.

    How often does DH beat earnings estimates?

    Definitive Healthcare beat the EPS estimate in 5 of the last 8 quarters, with an average surprise of +37.89%.